Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S1617

Introduced
2/27/25  
Refer
2/27/25  

Caption

Prohibiting the sale of dextromethorphan to minors

Impact

If enacted, S1617 will amend Chapter 94C of the Massachusetts General Laws by instituting strict age verification procedures for the purchase of products containing dextromethorphan. Retailers will be required to check for photo identification to ensure that the purchaser is 18 or older, introducing a new layer of responsibility for businesses selling these products. Furthermore, the bill preempts any local ordinance that regulates the selling, distribution, receipt, or possession of dextromethorphan, thus ensuring a uniform standard across the state.

Summary

Bill S1617, introduced by Senator Rebecca L. Rausch, seeks to prohibit the sale of dextromethorphan, an active ingredient in many over-the-counter cough suppressants, to individuals under 18 years of age. The legislation aims to address increasing concerns regarding the misuse of this substance by minors, who may use it recreationally to achieve euphoric effects. The bill acknowledges the need for regulation in protecting young people from potential health risks associated with unsupervised consumption of such substances.

Conclusion

Ultimately, S1617 represents an effort to take proactive measures in public health policy concerning substance use among youth. By targeting the sale of dextromethorphan, the bill aims to mitigate associated risks and currently aligns with similar measures being considered or enacted in other states. The legislative discussions surrounding this bill will likely reflect broader concerns about substance control and the role of government in regulating access to substances that, while legal, present significant risks when misused.

Contention

The bill has the potential to spark discussions regarding public health versus personal freedom. Proponents argue that the bill is essential to curb misuse among minors and protect their health, while opponents may raise concerns about government overreach and the implications of restricting access to legal products. Additionally, the enforcement mechanisms, including fines for shops failing to adhere to the new regulations, may be contested, especially among retailers concerned about increased liability.

Companion Bills

No companion bills found.

Previously Filed As

MA H2481

Prohibiting the sale of dextromethorphan to minors

MA S1249

Prohibiting body size discrimination

MA H1919

Prohibiting body size discrimination

MA H136

Prohibiting the use and sale of toxic sludge

MA S0751

Prohibition of sale of nitrous oxide to minors

MA S551

Prohibiting the sale of newly farmed fur products

MA H990

Prohibiting the sale of newly farmed fur products

MA S1023

Relative to the creation of a chapter 40B commission

MA SB1095

Gender transition; minors; prohibitions

MA HB2085

Gender transition; minors; prohibitions.

Similar Bills

MA H2481

Prohibiting the sale of dextromethorphan to minors

MO HB609

Modifies provisions relating to health care providers

MS HB448

Uniform Controlled Substances Law; exclude hypodermic syringes from definition of paraphernalia.

MS HB838

Uniform Controlled Substances Law; exclude hypodermic syringes from definition of paraphernalia.

MD SB327

Criminal Law - Drug Paraphernalia and Controlled Paraphernalia Prohibitions - Repeal

MD HB551

Criminal Law - Drug Paraphernalia and Controlled Paraphernalia Prohibitions - Repeal

IL HB1811

CONTROLLED SUB-PMP-INTERSTATE

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.